New Myostatin Blocker Omega-3 News

Myostatin Blocker Hype vs. Reality, and Should You Still Take Omega-3s? In this Fourth of July Iron Radio episode, Coach Phil Stevens introduces a newly publicized myostatin-blocking drug, Trevogrumab (Regeneron), which promises dose-dependent muscle gain by blocking the myostatin pathway. Phil flags a viral social media clip hyping the compound, while noting that buried in early trial data is a troubling adverse event: 5 of 45 subjects experienced death. Dr. Lonnie Lowery and Dr. Mike T. Nelson dig into the science — what we know about myostatin knockout in animals and a rare German double-null child, the question of whether resistance training is even necessary with such a drug, and the dangers of underground use without sterility or verified sourcing. In the second segment, Dr. Lonnie covers a "clickbait" Supply Side Journal article questioning Omega-3 value based on preclinical and conflicting observational data. Dr. Mike discusses his decade-plus practice of testing red blood cell Omega-3 levels with Dr. Dibbus, targeting 8–9% RBC levels, current dosing considerations, and why farmed salmon's changed feed now makes supplementation even more critical. 00:00 Welcome and Hosts 01:27 Fourth of July News Episode Setup 01:46 Myostatin Blocker Trevogrumab Introduction 05:00 Trial Deaths and Safety Red Flags 07:53 Myostatin Science and Animal Models 10:27 Underground Use and Anecdotal Reports 13:00 Social Media Influence and Gen Pop Risk 16:07 Show Announcements and Promos 19:10 AI Check on Trevogrumab Side Effects 21:00 Golden Dilemma and Risk Acceptance 24:51 Omega-3 News: Clickbait or Real Science? 29:06 Phil on High-Dose Fish Oil History 30:21 Mike on Omega-3 Testing Protocol 34:00 Farmed Salmon and Supplement Rationale 35:48 Wrap and Happy Fourth of July Donate to the show via PayPal HERE.You can also join Dr Mike's Insider Newsletter for more info on how to add muscle, improve your performance and body comp - all without destroying your health, go to www.ironradiodrmike.com Thank you!Phil, Jerrell, Mike T, and Lonnie